Skip to content

Improving cognitive function through forest healing.

Verification of the effect of improving symtpoms of cognitive impairment through forest healing program.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0007318
Enrollment
220
Registered
2022-05-20
Start date
2022-04-01
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Behavioral : The forest therapy group is assigned to a group of 3 to 5 people, distributes the schedule, and participates in the forest program once a week (around 2 hours in the morning or in the a

Sponsors

Hallym University Medical Center- Chuncheon
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Adults 55 years of age or older 2) Patients with or without depression who meet the diagnostic criteria for mild cognitive impairment (A patient with a score of 0.5-2 in CDR or 2-5 in GDS and mild cognitive impairment with memory complaint, normal activities of daily living, normal general cognitive function, abnormal memory for age, and not demented) 3) A person who can read and understand the subject's explanation and consent form, and is capable of language skills at a level that can respond to questionnaires 4) A person who voluntarily decides to participate in this clinical trial and agrees to the consent form for research subject participation and can participate in the entire clinical trial period

Exclusion criteria

Exclusion criteria: 1) Those diagnosed with bipolar or psychotic major depressive disorder 2) Those with a history of uniaxial psychiatric disorders including intellectual disability, schizophrenia, alcoholism, and bipolar disorder 3) Stroke, convulsive disease, Parkinson's disease, multiple sclerosis, cerebral palsy, Huntington's disease, encephalitis, meningitis, liver disease beyond cirrhosis, kidney disease to the extent that dialysis is required patient 4) Those with a history of convulsions 5) Those who have found other neurological abnormalities that may cause memory impairment on medical examination 6) When it is judged that there is a problem in attaching EEG and DC stimulation electrodes due to scalp deformity, inflammatory reaction, or other dermatological problems 7) Those who have had cancer within the past 3 years 8) Those who have undergone cerebrovascular surgery, such as brain surgery or carotid artery surgery 9) Those who have difficulty breathing when sitting still 10) Those who have abused drugs in the past 5 years

Design outcomes

Primary

MeasureTime frame
brain function: electroencephalography(EEG), functional near-infrared spectroscopy ;Cognitive function: short-term memory, working memory, attention, executive function;psychological symtpoms: depression and anxiety;physical and physiological function: gait speed, functional mobility, blood pressure, pulse, temperature

Secondary

MeasureTime frame
blood biomarker: BDNF, IL1,6, amyloid beta, tau protein

Countries

Korea, Republic of

Contacts

Public ContactJiheon Kim

Hallym University Medical Center- Chuncheon

ros205@daum.net+82-33-240-5000

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026